Prostate cancer · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Suramin and Hydrocortisone Variant #01 | — | R 2 280 977 | 78d | — | — | ~1 | ~R 2 280 977 indirect | — |
Suramin monotherapy Variant #01 | — | R 1 270 448 | 28d | — | — | ~1 | ~R 1 270 448 indirect | — |
CMF Variant #01 | — | R 291 | 28d | — | ~21.5 mo | ~2 | ~R 582 PFS proxy · indirect | 4 |
3 of 3 regimens shown